Abstract Efficient and scalable chemical approaches to 3, 5, 7-trisubstituted 1H-indazoles were developed and applied to the synthesis of 1, 1-dimethylethyl 4-[7-(aminocarbonyl)-5- bromo-1H-indazol-3-yl]-1-piperidinecarboxylate, a key intermediate for 3, 5, 7-trisubstituted 1H-indazole, which was identified as a potent IKK2 inhibitor. The sequence allows for a scalable preparation of the target compound in eight steps and proceeds in 40% overall ...